Processed EEG and non-invasive cerebral oximetry (cerebral rSO2) monitoring in transcatheter aortic valve implantation

  • Marija Raquel Caetano CHVNG and CHP Anesthesiology and Emergency Departments, Porto, (Portugal)
  • Ana Luisa Veiga De Sa Centro Hospitalar do Porto, Dept. of Anaesthesiology, Critical Care & Emergency Medicine, Porto, (Portugal)
  • Joana Barrcuo Moreira Centro Hospitalar do Porto, Dept. of Anaesthesiology, Critical Care & Emergency Medicine, Porto, (Portugal)
  • Manuel Antsuzo F. Traila Campos Centro Hospitalar do Porto, Dept. of Anaesthesiology, Critical Care & Emergency Medicine, Porto, (Portugal)
Keywords: Processed EEG, Cerebral Non-Invasive Oximetry- rSO, Aortic Stenosis, TAVI, Neuromonitoring

Abstract

Transcatheter aortic-valve implantation (TAVI) has been suggested as a less invasive treatment for high-risk patients with aortic stenosis. Ischemic events remain a troublesome risk following TAVI. The use of neuromonitoring with cerebral rSO2 and Processed EEG may contribute to detect and correct imbalances in the oxygen demand-to-delivery ratio.

We describe two clinical cases of TAVI procedure-related complications with cerebrovascular repercussions that reflected on cerebral oximetry and electrical activity as detected by NIRS and processed EEG. Cerebral rSO2 and processed raw EEG monitoring is relevant and useful in this setting, enabling clinicians to identify and possibly take preventive/corrective actions on the peri-operative setting, in order to minimize secondary damage due to ischemic/hypoxic events.

Published
01-16-2019
How to Cite
Caetano, M. R., Sa, A. L. V. D., Moreira, J. B., & Campos, M. A. F. T. (2019). Processed EEG and non-invasive cerebral oximetry (cerebral rSO2) monitoring in transcatheter aortic valve implantation. Anaesthesia, Pain & Intensive Care, 22(1), 105-108. Retrieved from https://apicareonline.com/index.php/APIC/article/view/4
Issue
Vol.22 No.1(2018): January-March
Section
Case Reports